Listed

Eledon Pharmaceuticals, Inc.

ELDNNasdaqCIK 1404281HealthcareFiscal year ends Dec 31

Reports and events: 214 filings

Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.

What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.

Eledon Pharmaceuticals, Inc., Reports and events
FiledFormWhat it isAccession number
2020-11-1617:02 ET10-QQuarterly reportPeriod 2020-09-300001564590-20-054210
2020-10-1421:20 ETSC 13D/AOwnership report, active investor, amended0000947871-20-000795
2020-10-0616:45 ET8-K5.03 Amendment to articles or bylaws; 9.01 Financial statements and exhibits0001193125-20-264806
2020-09-1517:19 ET8-K1.01 Entry into a material agreement; 2.01 Completion of an acquisition or disposition; 3.02 Unregistered sale of equity; 5.02 Departure or appointment of officers or directors; 5.03 Amendment to articles or bylaws; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001193125-20-246314
2020-09-0416:25 ET8-K5.02 Departure or appointment of officers or directors0001193125-20-240108
2020-08-1816:35 ETSC 13D/AOwnership report, active investor, amended0000947871-20-000691
2020-08-1419:38 ET10-QQuarterly reportPeriod 2020-06-300001564590-20-040128
2020-06-1716:05 ET8-K2.05 Exit or disposal costs; 5.02 Departure or appointment of officers or directors0001564590-20-029654
2020-05-1506:32 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001564590-20-025631
2020-05-1506:02 ET10-QQuarterly reportPeriod 2020-03-310001564590-20-025612
2020-05-1316:00 ET8-K5.07 Shareholder vote results0001564590-20-025038
2020-04-2306:03 ET8-K3.01 Delisting notice0001564590-20-018029
2020-03-3116:00 ETDEF 14AProxy statementPeriod 2020-05-120001564590-20-014525
2020-03-2516:06 ETS-1Registration statement0001193125-20-085060
2020-03-1706:03 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001564590-20-011277
2020-03-1720:46 ET10-KAnnual reportPeriod 2019-12-310001564590-20-011260
2020-02-2517:04 ETSC 13D/AOwnership report, active investor, amended0000947871-20-000143
2020-02-2006:12 ET8-K/A3.02 Unregistered sale of equity; 5.03 Amendment to articles or bylaws; 9.01 Financial statements and exhibits0001193125-20-042564
2020-02-1916:11 ET8-K3.02 Unregistered sale of equity; 5.03 Amendment to articles or bylaws; 9.01 Financial statements and exhibits0001193125-20-041903
2020-02-0718:00 ET8-K3.01 Delisting notice0001564590-20-003758
2020-01-1606:32 ET8-K1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits0001193125-20-008426
2019-11-1306:00 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001564590-19-043080
2019-11-1318:01 ET10-QQuarterly reportPeriod 2019-09-300001564590-19-043039
2019-08-1316:37 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001564590-19-031828
2019-08-1316:06 ET10-QQuarterly reportPeriod 2019-06-300001564590-19-031785
2019-08-0917:30 ET8-K3.01 Delisting notice0001193125-19-218112
2019-07-1216:05 ET8-K4.01 Change of auditor; 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits0001193125-19-193205
2019-06-0716:07 ETS-1Registration statement0001193125-19-168171
2019-05-1516:30 ETDEF 14AProxy statementPeriod 2019-07-110001564590-19-019430
2019-05-1416:30 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001564590-19-019162
2019-05-1416:06 ET10-QQuarterly reportPeriod 2019-03-310001564590-19-019134
2019-05-0617:01 ETSC 13D/AOwnership report, active investor, amended0000947871-19-000328
2019-05-0216:24 ET8-K1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 8.01 Other events; 9.01 Financial statements and exhibits0001193125-19-135059
2019-04-3016:05 ET10-K/AAnnual report, amendedPeriod 2018-12-310001193125-19-129270
2019-04-2208:02 ET8-K8.01 Other events; 9.01 Financial statements and exhibits0001564590-19-012158
2019-04-0507:32 ETSC 13D/AOwnership report, active investor, amended0001104659-19-020047
2019-03-2806:04 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001564590-19-009676
2019-03-2817:53 ET10-KAnnual reportPeriod 2018-12-310001564590-19-009631
2019-01-0812:49 ET8-K7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001564590-19-000367
2018-11-1307:58 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001564590-18-029134
2018-11-1317:45 ET10-QQuarterly reportPeriod 2018-09-300001564590-18-028982
2018-09-0416:38 ETS-1/ARegistration statement, amended0001193125-18-266270
2018-08-0708:31 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001564590-18-019667
2018-08-0717:43 ET10-QQuarterly reportPeriod 2018-06-300001564590-18-019519
2018-08-0118:00 ETS-1Registration statement0001193125-18-233511
2018-06-1417:24 ET8-K5.07 Shareholder vote results0001564590-18-015631
2018-05-1516:22 ETSC 13D/AOwnership report, active investor, amended0001072613-18-000344
2018-05-1119:38 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001564590-18-013100
2018-05-1119:19 ET10-QQuarterly reportPeriod 2018-03-310001564590-18-013090
2018-05-0217:12 ETSC 13D/AOwnership report, active investor, amended0001072613-18-000306

Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Nov 13, 2026, 16:16 ET. Listed shows no prices and gives no investment advice.